SciNeuro

Business Services · Maryland, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

9808 Medical Center Dr Ste 470, Rockvill...

Revenue

$7.4 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1

About SciNeuro

SciNeuro Pharmaceuticals is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases. Since its founding in 2020, SciNeuro has built a portfolio of pipeline programs staged from discovery to clinical development by addressing three key disease-driving mechanisms of neurodegeneration neurovascular inflammation, proteinopathy, and immune response. The company aims to develop disease-modifying treatment options for Alzheimer's disease, Parkinson's disease, and other devastating CNS diseases.Explore more
SciNeuro's Social MediaPopular SearchesSciNeuro PharmaceuticalsSciNeuroSIC Code 87,873NAICS Code 54,541Show more

SciNeuro Org Chart

PhoneEmail
SA
United States flag for contact location.

Chief Marketing Officer

PhoneEmail
Hogan Wan, Chief Financial Officer at SciNeuro
United States flag for contact location.

Chief Financial Officer

PhoneEmail
QA
United States flag for contact location.

Chief Medical Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
Paul Stead, Chief Brand Officer at SciNeuro
United States flag for contact location.

Chief Brand Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is SciNeuro your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to SciNeuro

Compare insights from companies similar to SciNeuro, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

SciNeuro

$7.4M
11-50
Private
$53M
2020
SA
Samuel AgusChief Marketing Officer
$13.2M
51-200
Public
$214.1M
2012
JX
James XueChairman, President & CEO
$7.1M
11-50
Private
-
2001
DS
David SolomonMedical Director
$6.7M
11-50
Private
$74.8M
2006
N/A
$6M
11-50
Private
-
1986
N/A
<$5M
1-10
Private
-
2020
N/A
<$5M
11-50
Private
-
1998
TB
Terry BowlinPresident & CEO
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

SciNeuro is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

SciNeuro is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about SciNeuro.

SciNeuro financials insights

Gather financial insights about SciNeuro, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2025

Private Equity

$53M

See All SciNeuro's Financials Insights

SciNeuro Tech Stack

Most Recent Scoops

Funding
Funding
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
New Hire
Executive Move
See more scoops

Top Business Services Companies

Frequently Asked Questions Regarding SciNeuro

What is SciNeuro's official website?
SciNeuro's official website is www.scineuro.com
What is SciNeuro's Revenue?
SciNeuro's revenue is $7.4 Million
What is SciNeuro's SIC code?
SciNeuro's SIC: 87,873
What is SciNeuro's NAICS code?
SciNeuro's NAICS: 54,541
How many employees does SciNeuro have?
SciNeuro has 11-50 employees
What industry does SciNeuro belong to?
SciNeuro is in the industry of: Business Services, Research & Development
What is SciNeuro competition?
SciNeuro top competitors include: Aronex Pharmaceuticals, CANbridge Pharmaceuticals, Presidio Pharmaceuticals, Carrot Capital
What technology does SciNeuro use?
Some of the popular technologies that SciNeuro uses are: Cloudflare Rocket Loader, WordPress.org, PHP, Cloudflare Website Optimization
Who is the CFO of SciNeuro?
SciNeuro's CFO is Hogan Wan
What does SciNeuro do?

SciNeuro Pharmaceuticals is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases. Since its founding in 2020, SciNeuro has built a portfolio of pipeline programs staged from discovery to clinical development by addressing three key disease-driving mechanisms of neurodegeneration neurov... ascular inflammation, proteinopathy, and immune response. The company aims to develop disease-modifying treatment options for Alzheimer's disease, Parkinson's disease, and other devastating CNS diseases.Read More

What are SciNeuro social media links?
SciNeuro Linkedin page
Is SciNeuro a public company?
SciNeuro is private company therefore does not currently have an official ticker symbol
See more information about SciNeuro

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.